
Keywords: LGMD, limb-girdle muscular dystrophy; SG, sarcoglycan; DGC, dystrophin-glycoprotein complex; IHC, immunohistochemistry; CK, creatine kinaseLimb-girdle muscular dystrophy type 2D; Sarcoglycan; Sarcoglycanopathy; The SGCA gene; Founder mutation; Taiwan